Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;32(3):333-40.
doi: 10.1016/j.healun.2012.11.026.

Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation

Tomoko S Kato  1 , Gerin R Stevens, Jeffrey Jiang, P Christian Schulze, Natalie Gukasyan, Matthew Lippel, Alison Levin, Shunichi Homma, Donna Mancini, Maryjane Farr
Affiliations

Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation

Tomoko S Kato et al. J Heart Lung Transplant. 2013 Mar.

Abstract

Background: Risk stratification of ambulatory heart failure (HF) patients has relied on peak VO(2)<14 ml/kg/min. We investigated whether additional clinical variables might further specify risk of death, ventricular assist device (VAD) implantation (INTERMACS <4) or heart transplantation (HTx, Status 1A or 1B) within 1 year after HTx evaluation. We hypothesized that right ventricular stroke work index (RVSWI), pulmonary capillary wedge pressure (PCWP) and the model for end-stage liver disease-albumin score (MELD-A) would be additive prognostic predictors.

Methods: We retrospectively collected data on 151 ambulatory patients undergoing HTx evaluation. Primary outcomes were defined as HTx, LVAD or death within 1 year after evaluation.

Results: Average age in our cohort was 55 ± 11.1 years, 79.1% were male and 39% had an ischemic etiology (LVEF 21 ± 10.5% and peak VO(2) 12.6 ± 3.5 ml/kg/min). Fifty outcomes (33.1%) were observed (27 HTxs, 15 VADs and 8 deaths). Univariate logistic regression showed a significant association of RVSWI (OR 0.47, p = 0.036), PCWP (OR 2.65, p = 0.007) and MELD-A (OR 2.73, p = 0.006) with 1-year events. Stepwise regression showed an independent correlation of RVSWI<5gm-m(2)/beat (OR 6.70, p < 0.01), PCWP>20 mm Hg (OR 5.48, p < 0.01), MELD-A>14 (OR 3.72, p< 0.01) and peak VO(2)<14 ml/kg/min (OR 3.36, p = 0.024) with 1-year events. A scoring system was developed: MELD-A>14 and peak VO(2)<14-1 point each; and PCWP>20 and RVSWI<5-2 points each. A cut-off at≥4 demonstrated a 54% sensitivity and 88% specificity for 1-year events.

Conclusions: Ambulatory HF patients have significant 1-year event rates. Risk stratification based on exercise performance, left-sided congestion, right ventricular dysfunction and liver congestion allows prediction of 1-year prognosis. Our findings support early and timely referral for VAD and/or transplant.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Kaplan-Meier curves of patients undergoing HTx evaluation with our risk-stratification model score ≥4 and <4
The end-point was set as death/HTx as Status 1A o 1B /mechanical circulatory support requirement as INTERMACS Level < 4.
Figure 2
Figure 2. Receiver operating characteristic curves for our risk-stratification model and HFSS (A) and co-variable included in our risk-stratification model (B) associated with death/HTx/mechanical circulatory support requirement within one-year after HTx evaluation
Blue line indicates the ROC curve of our risk-stratification model, and red line indicates HFSS.
See this image and copyright information in PMC

References

    1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report—2011. J Heart Lung Transplant. 2011;30:1078–94. - PubMed
    1. Jaski BE, Kim JC, Naftel DC, et al. Cardiac Transplant Research Database Research Group. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. J Heart and Lung Transplant. 2001;20:449–56. - PubMed
    1. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–7. - PubMed
    1. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433. - PubMed
    1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778–86. - PubMed

Publication types